The stock's fall snapped a four-day winning streak.

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...

Henry Schein has acquired R. Weinstein, Inc., a provider of vaccines, medical-surgical products and equipment to Hawaii-based health care facilities and practitioners.

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Henry Schein HSIC in the last three months. The table below summarizes their recent ratings ...

MELVILLE, N.Y., February 26, 2025--(BUSINESS WIRE)--In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq ...

Feb 25 (Reuters) - Henry Schein (HSIC.O), opens new tab forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid ...

Shareholders might have noticed that Henry Schein, Inc. (NASDAQ:HSIC) filed its annual result this time last week. The early response was not positive, with shares down 7.6% to US$72.12 in the ...

Henry Schein Inc. closed 14.16% short of its 52-week high of $82.49, which the company reached on February 5th.

MELVILLE, N.Y. (AP) — MELVILLE, N.Y. (AP) — Henry Schein Inc. (HSIC) on Tuesday reported fourth-quarter profit of $94 million. The Melville, New York-based company said it had net income of 74 ...

Explore Henry Schein's Q4 2024 earnings insights, including strategic growth plans, KKR partnership, and financial performance.